Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme
- PMID: 8168112
Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme
Abstract
Glioblastomas were examined for abnormalities in fibroblast growth factor receptor (FGFR) expression by polymerase chain reaction and immunocytochemical analysis. Polymerase chain reaction analysis demonstrated that FGFR1 mRNA levels were significantly higher in glioblastomas than in normal brain adjacent to the tumor or in untransformed human brain. These results were consistent with immunocytochemical localization of FGFR1 protein in glioblastomas: glioblastoma cells exhibited intense FGFR1 immunoreactivity in frozen sections of tumor and low to undetectable FGFR1 immunoreactivity in adjacent normal brain or in normal white matter obtained from patients without neoplastic disease. Endothelial cells of capillaries and larger vessels within the tumor were devoid of FGFR1 immunoreactivity. All glioblastomas evaluated in the present study expressed FGFR1 mRNA and FGFR1 immunoreactivity. Examination of the FGFR1 gene by Southern blot analysis indicated that overexpression of FGFR1 mRNA in glioblastomas did not result from gene amplification. These results indicate that glioblastoma cells, in contrast to endothelial cells within the tumor, display increased levels of FGFR1. Therefore, FGFR1 signal transduction may be associated with increased autocrine growth activity of tumor cells and is probably not related to the increased endothelial cell proliferation associated with these tumors.
Similar articles
-
Endothelial cell KIT expression in human tumours.J Pathol. 2007 Mar;211(4):481-8. doi: 10.1002/path.2125. J Pathol. 2007. PMID: 17294421
-
Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors.Cancer Res. 2000 Mar 1;60(5):1221-4. Cancer Res. 2000. PMID: 10728679
-
[Expression of fibroblast growth factor receptors (FGFRs) mRNA in human astrocytomas].No To Shinkei. 1996 Apr;48(4):363-70. No To Shinkei. 1996. PMID: 8679334 Japanese.
-
Expression and cellular localization of messenger RNA for plasminogen activator inhibitor type 1 in human astrocytomas in vivo.Cancer Res. 1994 Jul 1;54(13):3329-32. Cancer Res. 1994. PMID: 8012944
-
Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas.J Neurooncol. 1994;18(3):207-16. doi: 10.1007/BF01328955. J Neurooncol. 1994. PMID: 7964981 Review.
Cited by
-
HSPA5 and FGFR1 genes in the mesenchymal subtype of glioblastoma can improve a treatment efficacy.Anim Cells Syst (Seoul). 2024 May 18;28(1):216-227. doi: 10.1080/19768354.2024.2347538. eCollection 2024. Anim Cells Syst (Seoul). 2024. PMID: 38770056 Free PMC article.
-
Molecular basis of VEGFR1 autoinhibition at the plasma membrane.Nat Commun. 2024 Feb 14;15(1):1346. doi: 10.1038/s41467-024-45499-2. Nat Commun. 2024. PMID: 38355851 Free PMC article.
-
Exploring the Past, Present, and Future of Anti-Angiogenic Therapy in Glioblastoma.Cancers (Basel). 2023 Jan 29;15(3):830. doi: 10.3390/cancers15030830. Cancers (Basel). 2023. PMID: 36765787 Free PMC article. Review.
-
Targeting Protein Kinase C in Glioblastoma Treatment.Biomedicines. 2021 Apr 4;9(4):381. doi: 10.3390/biomedicines9040381. Biomedicines. 2021. PMID: 33916593 Free PMC article. Review.
-
Depletion of CLK2 sensitizes glioma stem-like cells to PI3K/mTOR and FGFR inhibitors.Am J Cancer Res. 2020 Nov 1;10(11):3765-3783. eCollection 2020. Am J Cancer Res. 2020. PMID: 33294266 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous